AMS vs SERA: stock comparison and AI forecast
American Shared Hospital Services (AMS) and Sera Prognostics, Inc. (SERA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AMS American Shared Hospital Services
- Price
- $1.25 -32.1% · 6M
- Market Cap
- $8M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SERA Sera Prognostics, Inc.
- Price
- $1.99 +4.7% · 6M
- Market Cap
- $78M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- SERA is 9.4 times larger than AMS by market capitalization ($78M against $8M).
- Over the last six months SERA returned +4.7% and AMS -32.1%.
- AMS turns -6.6% of its revenue into net income, against -47475.7% for SERA.
- AMS carries 1.15 times debt per unit of equity, against 0.46 times for SERA.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AMS | SERA |
|---|---|---|
| Market Cap | $8M | $78M |
| P/B Ratio | 0.36x | 1.32x |
| EPS | $-0.26 | $-0.69 |
| Book Value/Share | $3.48 | $1.51 |
| Revenue/Share | $5.49 | $0.00 |
| FCF/Share | $0.53 | $-0.71 |
Profitability & Margins
| Metric | AMS | SERA |
|---|---|---|
| ROE | -10.4% | -56.0% |
| ROA | -4.6% | -38.3% |
| ROIC | -16.2% | -59.8% |
| Gross Margin | 16.9% | -152.9% |
| Operating Margin | -13.4% | -53282.9% |
| Net Margin | -6.6% | -47475.7% |
| EBT Margin | -12.2% | -46745.7% |
| Tax Rate | 5.5% | – |
Financial Health
| Metric | AMS | SERA |
|---|---|---|
| Current Ratio | 0.77x | 1.98x |
| D/E Ratio | 1.15x | 0.46x |
| Financial Leverage | 2.27x | 1.46x |
| Interest Coverage | -3.0x | -5002.0x |
| Working Capital | -$5M | $24M |
Cash Flow
| Metric | AMS | SERA |
|---|---|---|
| Operating Cash Flow | $5M | -$28M |
| Free Cash Flow | $4M | -$28M |
| Capital Spending | -$2M | -$470K |
| FCF/Sales | 9.7% | -40211.4% |
| CapEx/Sales | 5.0% | 665.7% |
Operational Efficiency
| Metric | AMS | SERA |
|---|---|---|
| Asset Turnover | 0.70x | 0.00x |
| Receivables Turnover | 4.4x | 7.0x |
| Fixed Assets Turnover | – | 0.1x |
| Days Sales Outstanding | 83 days | 52 days |
| Payables Period | 7 days | 2482 days |
Income Statement
| Metric | AMS | SERA |
|---|---|---|
| Total Revenue | $37M | $70K |
| Operating Income | -$5M | -$37M |
| Net Income | -$2M | -$33M |
| R&D Expense | – | $13M |
| SG&A Expense | $9M | $31M |
| Cost of Goods Sold | $30M | $170K |
Dividend & Shareholder Information
| Metric | AMS | SERA |
|---|---|---|
| Shares Outstanding | 7M | 39M |
AMS vs SERA: stock comparison and AI forecast
Which is bigger, AMS or SERA?
SERA is 9.4 times larger than AMS by market capitalization ($78M against $8M).
Which stock performed better over the last six months, AMS or SERA?
Over the last six months SERA returned +4.7% and AMS -32.1%.
Which one does Intratio's AI model rank higher, AMS or SERA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.